Evaluation of a Novel Boron-Containing α-<span style="font-variant: small-caps">d</span>-Mannopyranoside for BNCT

Evaluation of a Novel Boron-Containing α-<span style="font-variant: small-caps">d</span>-Mannopyranoside for BNCT

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine (BPA) and sodium borocaptate (BSH) used as <sup>10</sup>B delivery agents. However, continuous drug administration at...

Full description

Bibliographic Details
Main Authors: Takao Tsurubuchi, Makoto Shirakawa, Wataru Kurosawa, Kayo Matsumoto, Risa Ubagai, Hiroshi Umishio, Yasuyo Suga, Junko Yamazaki, Akihiro Arakawa, Yutaka Maruyama, Takuya Seki, Yusuke Shibui, Fumiyo Yoshida, Alexander Zaboronok, Minoru Suzuki, Yoshinori Sakurai, Hiroki Tanaka, Kei Nakai, Eiichi Ishikawa, Akira Matsumura
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cells
Subjects:
boron-containing α-<span style="font-variant: small-caps">d</span>-mannopyranoside
closo-dodecarborate
low-molecular-weight compound
BNCT
Online Access:https://www.mdpi.com/2073-4409/9/5/1277

Internet

https://www.mdpi.com/2073-4409/9/5/1277

Similar Items